0001209191-13-027656.txt : 20130520 0001209191-13-027656.hdr.sgml : 20130520 20130520182018 ACCESSION NUMBER: 0001209191-13-027656 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20130516 FILED AS OF DATE: 20130520 DATE AS OF CHANGE: 20130520 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Galen Management, LLC CENTRAL INDEX KEY: 0001421162 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-10113 FILM NUMBER: 13859761 BUSINESS ADDRESS: BUSINESS PHONE: 203 654 6400 MAIL ADDRESS: STREET 1: 680 WASHINGTON BLVD CITY: STAMFORD STATE: CT ZIP: 06901 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ACURA PHARMACEUTICALS, INC CENTRAL INDEX KEY: 0000786947 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 110853640 STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 616 N. NORTH COURT, SUITE 120 CITY: PALATINE STATE: IL ZIP: 60067 BUSINESS PHONE: 847-705-7709 MAIL ADDRESS: STREET 1: 616 N. NORTH COURT, SUITE 120 STREET 2: . CITY: PALATINE STATE: IL ZIP: 60067 FORMER COMPANY: FORMER CONFORMED NAME: HALSEY DRUG CO INC/NEW DATE OF NAME CHANGE: 19920703 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GALEN PARTNERS III L P CENTRAL INDEX KEY: 0001034486 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-10113 FILM NUMBER: 13859760 BUSINESS ADDRESS: STREET 1: 610 FIFTH AVE STREET 2: 5TH FL CITY: NEW YORK STATE: NY ZIP: 10020 BUSINESS PHONE: 2122184990 MAIL ADDRESS: STREET 1: 610 FIFTH AVE STREET 2: 5TH FL CITY: NEW YORK STATE: NY ZIP: 10020 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GALEN PARTNERS INTERNATIONAL III L P CENTRAL INDEX KEY: 0001034574 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-10113 FILM NUMBER: 13859763 BUSINESS ADDRESS: STREET 1: 610 FIFTH AVENUE 5TH FLOOR STREET 2: C/O GALEN ASSOCIATES CITY: NEW YORK STATE: NY ZIP: 10020 BUSINESS PHONE: 2122184990 MAIL ADDRESS: STREET 1: 610 FIFTH AVENUE 5TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10020 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GALEN EMPLOYEE FUND III LP CENTRAL INDEX KEY: 0001056642 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-10113 FILM NUMBER: 13859762 BUSINESS ADDRESS: STREET 1: 610 FIFTH AVENUE 5TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10020 BUSINESS PHONE: 2122184990 MAIL ADDRESS: STREET 1: 610 FIFTH AVENUE 5TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10020 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: CLAUDIUS LLC CENTRAL INDEX KEY: 0001056643 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-10113 FILM NUMBER: 13859764 BUSINESS ADDRESS: STREET 1: 610 FIFTH AVENUE 5TH FLOOR STREET 2: C/O GALEN ASSOCIATES CITY: NEW YORK STATE: NY ZIP: 10020 BUSINESS PHONE: 2122184990 MAIL ADDRESS: STREET 1: C/O GALEN ASSOCIATES STREET 2: 610 FIFTH AVENUE 5TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10020 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2013-05-16 0 0000786947 ACURA PHARMACEUTICALS, INC ACUR 0001056643 CLAUDIUS LLC C/O GALEN MANAGEMENT, L.L.C. 680 WASHINGTON BLVD. STAMFORD CT 06901 0 0 1 0 0001034574 GALEN PARTNERS INTERNATIONAL III L P C/O GALEN MANAGEMENT, L.L.C. 680 WASHINGTON BLVD. STAMFORD CT 06901 0 0 1 0 0001056642 GALEN EMPLOYEE FUND III LP C/O GALEN MANAGEMENT L.L.C. 680 WASHINGTON BLVD. STAMFORD CT 06901 0 0 1 0 0001421162 Galen Management, LLC 680 WASHINGTON BLVD. STAMFORD CT 06901 0 0 1 0 0001034486 GALEN PARTNERS III L P C/O GALEN MANAGEMENT, L.L.C. 680 WASHINGTON BLVD. STAMFORD CT 06901 0 0 1 0 Common Stock 2013-05-16 4 S 0 42599 2.2088 D 12047898 I See FN Common Stock 2013-05-17 4 S 0 54460 2.3557 D 11993438 I See FN Common Stock 2013-05-20 4 S 0 68993 2.3949 D 11924445 I See FN The shares were sold as follows: 38,917 by Galen Partners III, L.P. ("Galen III"), 3,522 by Galen Partners International III, L.P. ("Galen International") and 160 by Galen Employee Fund III, L.P. ("Employee Fund"). The shares were sold at prices between $2.20 and $2.27. The Reporting Entities will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. The shares are held as follows: 11,009,488 by Galen III, 993,062 by Galen International and 45,348 by Employee Fund. Claudius, L.L.C. serves as the sole General Partner of Galen III and Galen International and has sole voting and investment control over the shares held by such funds and may be deemed to beneficially own the shares held by such funds. Galen Management, L.L.C. serves as the sole General Partner of Employee Fund and has sole voting and investment control over the shares held by Employee Fund and may be deemed to beneficially own the shares held by Employee Fund. Each of the Reporting Persons disclaims beneficial ownership of the shares reported herein, except to the extent of its respective pecuniary interest therein. The shares were sold as follows: 49,752 by Galen III, 4,503 by Galen International and 205 by Employee Fund. The shares were sold at prices between $2.34 and $2.39. The Reporting Entities will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. The shares are held as follows: 10,959,736 by Galen III, 988,559 by Galen International and 45,143 by Employee Fund. Claudius, L.L.C. serves as the sole General Partner of Galen III and Galen International and has sole voting and investment control over the shares held by such funds and may be deemed to beneficially own the shares held by such funds. Galen Management, L.L.C. serves as the sole General Partner of Employee Fund and has sole voting and investment control over the shares held by Employee Fund and may be deemed to beneficially own the shares held by Employee Fund. Each of the Reporting Persons disclaims beneficial ownership of the shares reported herein, except to the extent of its respective pecuniary interest therein. The shares were sold as follows: 63,029 by Galen III, 5,705 by Galen International and 259 by Employee Fund. The shares were sold at prices between $2.35 and $2.46. The Reporting Entities will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. The shares are held as follows: 10,896,707 by Galen III, 982,854 by Galen International and 44,884 by Employee Fund. Claudius, L.L.C. serves as the sole General Partner of Galen III and Galen International and has sole voting and investment control over the shares held by such funds and may be deemed to beneficially own the shares held by such funds. Galen Management, L.L.C. serves as the sole General Partner of Employee Fund and has sole voting and investment control over the shares held by Employee Fund and may be deemed to beneficially own the shares held by Employee Fund. Each of the Reporting Persons disclaims beneficial ownership of the shares reported herein, except to the extent of its respective pecuniary interest therein. /s/ David W. Jahns, Member of Claudius, L.L.C. 2013-05-20 /s/ David W. Jahns, Member of Claudius L.L.C., the General Partner of Galen Partners International III, L.P. 2013-05-20 /s/ David W. Jahns, Member Galen Management, L.L.C., the General Partner of Galen Employee Fund III, L.P. 2013-05-20 /s/ David W. Jahns, Member 2013-05-20 /s/ David W. Jahns, Member of Claudius, L.L.C., the General Partner of Galen Partners III, L.P. 2013-05-20